BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...

Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...

A research team has uncovered the genomic basis behind why some vine tea varieties accumulate far more dihydromyricetin than others.

Using multi-year field trials and transcriptome-wide allele-specific expression analyses, they showed maternal inbred choice can speed seed ...

The sequence Met-Glu-His-Phe-Pro-Gly-Pro gives Semax its hybrid nature: the ACTH fragment portion is thought to influence melanocortin-related signaling, while the PGP motif appears to impart ...

Caris AI Insights are proprietary and only available to Caris Life Sciences customers IRVING, Texas, April 8, 2026 ...

Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The Genome Partnership—the nonprofit organization that has organized the ...

Caris Life Sciences Inc. CAI shares are up during Wednesday’s premarket session following the announcement of finalized ...